ResearcherMethodist Dallas Medical CenterNo recent work listed
Alejandro Mejia
Matched on ORCID iD 0000-0002-5766-4321; OpenAlex author ID A5055573172.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 1 (principal investigator on 1)
- Pancreatic cancer grants
- 0
- Collaborators
- 1
2016: 1 trial · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers
Papers 2
- Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted… First author DOI 10.1007/s11701-022-01510-w↗
- Albumin-Bilirubin (ALBI) Score and Systemic Immune-Inflammation Indexes Used As Pretreatment Outcome Predictors in Patients With Pancreatic Ductal Adenocarcino… First author DOI 10.7759/cureus.50949↗
Trials 1
- Evaluation of Resection Techniques for Pancreatic Tumors Principal investigator NCT05128890↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Juan Carlos Barrera Gutierrez · 2 shared papers, 2023
- Paper Albumin-Bilirubin (ALBI) Score and Systemic Immune-Inflammation Indexes Used As Pretreatment Outcome Predictors in Pati… DOI 10.7759/cureus.50949↗
- Paper Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenect… DOI 10.1007/s11701-022-01510-w↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.